Dr. Chakrabarti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
612 Kingsborough Sq
Ste 100
Chesapeake, VA 23320Phone+1 757-547-9294Fax+1 757-213-9340
Education & Training
- University of MichiganResidency, Interventional Cardiology, 2006 - 2009
- Wayne State University School of MedicineClass of 2006
Certifications & Licensure
- VA State Medical License 2014 - 2026
- CA State Medical License 2023 - 2025
- MA State Medical License 2010 - 2025
- NC State Medical License 2014 - 2019
- MI State Medical License 2008 - 2012
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 77 citationsReduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51C. Michael Gibson, Anjan K. Chakrabarti, Jessica L. Mega, C. Bode, Jean-Pierre Bassand
Journal of the American College of Cardiology. 2013-07-23 - 11 citationsFatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary SyndromeC. Michael Gibson, Bennett Levitan, William J. Gibson, Megan K. Yee, Sabina A. Murphy
Journal of the American College of Cardiology. 2018-07-10 - 122 citationsEMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary pe...C. Michael Gibson, Robert P. Giugliano, Robert A. Kloner, Christoph Bode, Michal Tendera
European Heart Journal. 2016-04-21
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: